EASL Studio Podcast S7 E8: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?

EASL Studio S7 E8: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?

EASL Studio Podcast S7 E7: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies

EASL Studio S7 E7: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies

EASL Studio Podcast S7 E6: What’s hot and not in liver transplantation: EASL CPG 2024 update

EASL Studio S7 E6: What’s hot and not in liver transplantation: EASL CPG 2024 update

EASL Studio Podcast S7 E5: Why does WHO engagement with Steatotic Liver Disease matter?

EASL Studio S7 E5: Why does WHO engagement with Steatotic Liver Disease matter?

EASL Studio S7 E4: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?

EASL Studio Podcast S7 E4: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?

EASL Studio S7 E3: The changing face of Steatotic Liver Disease: Navigating new opportunities and emerging challenges

EASL Studio Podcast S7 E3: The changing face of Steatotic Liver Disease: Navigating new opportunities and emerging challenges

EASL Studio Elsewhere: Spotlight on Steatotic Liver Disease at INASL 2024

EASL Studio S7 E2: What does the future management of PBC look like?

EASL Studio Podcast S7 E2: What does the future management of PBC look like?

EASL Studio S7 E1: Are we relearning how to manage renal dysfunction in cirrhosis?

EASL Studio Podcast S7 E1: Are we relearning how to manage renal dysfunction in cirrhosis?

EASL Studio Podcast: Landmark studies at the EASL Congress 2024

EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam!

EASL Studio Podcast: Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention